Colgate-Palmolive (NYSE:CL) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of Colgate-Palmolive (NYSE:CL) from a buy rating to a hold rating in a research note published on Friday.

A number of other equities analysts have also issued reports on the stock. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research report on Friday. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. UBS Group reduced their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $89.80 on Friday. The firm has a market capitalization of $72.87 billion, a P/E ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company has a 50 day moving average price of $89.02 and a 200 day moving average price of $94.67. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm posted $0.87 earnings per share. Sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Institutional Investors Weigh In On Colgate-Palmolive

Institutional investors have recently added to or reduced their stakes in the stock. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth $26,000. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth $27,000. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter worth $31,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the 4th quarter worth $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive during the 4th quarter worth $32,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.